Invention Grant
- Patent Title: Stabilized soluble pre-fusion RSV F polypeptides
-
Application No.: US16589751Application Date: 2019-10-01
-
Publication No.: US11034731B2Publication Date: 2021-06-15
- Inventor: Johannes Petrus Maria Langedijk , Polina Furmanova Hollenstein
- Applicant: Janssen Vaccines & Prevention B.V.
- Applicant Address: NL Leiden
- Assignee: Janssen Vaccines & Prevention B.V.
- Current Assignee: Janssen Vaccines & Prevention B.V.
- Current Assignee Address: NL Leiden
- Agency: Ice Miller LLP
- Priority: EP15175654 20150707
- Main IPC: C07K14/005
- IPC: C07K14/005 ; A61P31/14 ; A61K39/12
Abstract:
Stable pre-fusion respiratory syncitial virus (RSV) F polypeptides, immunogenic compositions including the polypeptides, and uses thereof for the prevention and/or treatment of RSV infection are described.
Public/Granted literature
- US20200095287A1 STABILIZED SOLUBLE PRE-FUSION RSV F POLYPEPTIDES Public/Granted day:2020-03-26
Information query
